Filing Details

Accession Number:
0001214659-22-015198
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-21 21:20:26
Reporting Period:
2022-12-19
Accepted Time:
2022-12-21 21:20:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555337 D. David Meek C/O Mirati Therapeutics, Inc.
3545 Cray Court
San Diego CA 92121
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-19 35,425 $0.00 69,587 No 4 A Direct
Common Stock Disposition 2022-12-21 4,616 $40.41 64,971 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Award of Performance Stock Units ("PSUs"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the "Achievement Date" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Meek's continuous service.
  2. Includes 64 shares acquired under the ESPP Purchase on 5/31/2022 and 41 shares acquired under the ESPP purchase on 11/30/2022.
  3. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.